SM
FLNA

SG3 Management’s Filana Therapeutics FLNA Stock Holding History

SG3 Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-42,700
Closed -$1.26M – 146
2022
Q4 		$1.26M Buy
42,700
+22,300
+109% +$801K 0.18% 75
2022
Q3 		$853K Sell
20,400
-4,600
-18% -$124K 0.11% 114
2022
Q2 		$703K Sell
25,000
-25,000
-50% -$631K 0.08% 169
2022
Q1 		$1.86M Hold
50,000
– – 0.05% 310
2021
Q4 		$2.19M Sell
50,000
-45,000
-47% -$2.36M 0.04% 326
2021
Q3 		$5.9M Buy
95,000
+85,000
+850% +$7.09M 0.18% 115
2021
Q2 		$854K Sell
10,000
-80,000
-89% -$4.29M 0.03% 514
2021
Q1 		$4.05M Buy
+90,000
New +$3.54M 0.1% 226

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return